PTC Therapeutics | PTCT - 普通股股本



金融业
股票价格
USD
资产
USD 2.87B
现金及等价物
USD 833.99M
销售成本
USD 39.61M
流动资产
USD 2.25B
流动负债
USD 923.6M
债务
USD 286.94M
EBIT
USD 45.89M
EBITDA
USD -70.99M
员工
939
EPS每股收益
USD -0.03
股本和储备
USD -180.47M
销售毛利
USD 232.94M
债务利息支出
USD 2.87B
贷款资金
USD 286.94M
市值
USD 5.35B
净收入
USD -2.81M
营业费用
USD 226.67M
营业利润
USD 45.89M
普通股股本
USD 81.47M
PE价格收益
9.98
税前利润
USD -2.46M
销售收入
USD 273M
销售和管理费用
USD 73.89M
股票
USD 75.57M
贸易债权人
USD 25.48M
应收帐款人
USD 181.62M


普通股股本 更改 日
Acadia Pharmaceuticals USD 169.18M 470K 2025-12
Alnylam Pharmaceuticals USD 133.44M 1.07M 2026-03
Amgen USD 540M 1000K 2026-03
BioCryst Pharmaceuticals USD 213.06M 2.54M 2025-12
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 193.27M 969K 2026-03
Cytokinetics USD 124.43M 2.17M 2026-03
Daiichi Sankyo JPY 1.85B 9K 2025-12
Enanta Pharmaceuticals USD 212K 1000 2023-12
Esperion Therapeutics USD 245.22M 39.79M 2025-12
Gilead Sciences USD 1.24B 1000K 2026-03
Incyte USD 199.95M 1.49M 2026-03
Ionis Pharmaceuticals USD 165.9M 3.93M 2026-03
Ironwood Pharmaceuticals USD 160K 0 2024-12
Karyopharm Therapeutics USD 18.31M 18.3M 2025-12
Novartis USD 1.91B 60K 2026-03
Pfizer USD 5.7B 13M 2026-03
PTC Therapeutics USD 81.47M 1.54M 2025-12
Puma Biotechnology USD 5K 0 2024-06
Roche Holding CHF 795.62M 699.54K 2025-12
Sarepta Therapeutics USD 105.57M 607K 2026-03
TG Therapeutics USD 155.31M 95K 2025-12
Ultragenyx Pharmaceutical USD 98.3M 1.7M 2026-03
Vertex Pharmaceuticals USD 254.2M 200K 2026-03
Xencor USD 74.06M 2.19M 2026-03